Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if fludarabine, melphalan and
gemcitabine followed by transplantation of stem cells (blood-forming cells) as well as immune
cells (lymphocytes), collected from a matched related (i.e. a sibling) or unrelated donor, or
a mismatched related donor, can help to control Hodgkin's disease. The safety of the
treatment will also be studied.